Skip to main content

Home/ PharmaMics/ Group items tagged #medicalindustry

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
ramchintamaneni

ESMO: Kisqali shows superior overall survival in breast cancer - 0 views

www.clinicaltrialsarena.com/...esmo-novartis-kisqali

#esmo2019 #esmocongress #esmoconference #esmocongress2019 #drugdevelopment #medicalnews #medicalindustry

shared by ramchintamaneni on 07 Oct 19 - No Cached
  • ramchintamaneni on 07 Oct 19
     
    Novartis has announced results from the Monaleesa-3 trial at the European Society for Medical Oncology (ESMO) Congress 2019.
ramchintamaneni

ESMO 2019: ImmunoGen's ovarian cancer drug fails to meet PFS - 0 views

www.clinicaltrialsarena.com/...esmo-immunogen

#esmo2019 #esmocongress #esmoconference #ovariancancer #medicalnews #medicalindustry

shared by ramchintamaneni on 07 Oct 19 - No Cached
  • ramchintamaneni on 07 Oct 19
     
    ImmunoGen has presented full data from Phase 3 Forward I study of Mirvetuximab Soravtansine in ovarian cancer at the ESMO 2019 Congress in Barcelona, Spain.
ramchintamaneni

ESMO 2019: Merck unveils neoadjuvant/adjuvant TNBC trial results - 0 views

www.clinicaltrialsarena.com/...nt-adjuvant-tnbc-trial-results

#esmo2019 #esmocongress #esmoconference #esmocongress2019 #cancertreatment #medicalnews #medicalindustry

shared by ramchintamaneni on 09 Oct 19 - No Cached
  • ramchintamaneni on 09 Oct 19
     
    At ESMO 2019 Congress, Merck unveiled interim results from pivotal neoadjuvant/adjuvant phase 3 Keynote-522 trial during Presidential Symposium.
1 - 3 of 3
Showing 20▼ items per page